Enrico Carbone

Profile

The Banker Who Became a Builder

The fund was conceived inside a Stanford classroom. The room number was W250. That's now the name of the first fund - a detail that tells you something important about how Enrico Carbone operates. He remembers the room where things begin.

Carbone arrived at Stanford's Executive Program in 2018 carrying a 22-year career in global investment banking. He'd worked at Santander in Miami, moved through Credit Suisse and Merrill Lynch, and eventually became Partner and Managing Director at BR Partners - Brazil's largest independent investment bank - where he focused on mergers and acquisitions, capital markets, and financial restructuring.

Most people with that resume stay on that track. Carbone looked around the classroom at 150 fellow Stanford Executive Program and GSB alumni from 45 countries and saw something different: a deal network that had never been activated as a fund.

The result was Reaction - a Palo Alto-based impact VC that recruited those very classmates as LPs, deal sources, and portfolio advisors simultaneously. Not a fund that happened to have a network. A network that became a fund.

Co-founded with Dan Matthies, Reaction's stated mission is to improve one billion lives within a decade by identifying and scaling innovative solutions in health technology and climate innovation. Seed to Series B. Global reach. Measured outcomes. Carbone runs two funds in parallel: Reaction's W250 Venture Fund and Climate Innovations Fund, plus Irukandji Capital's Health Innovation Funds I and II. He also sits on the board of Health in Harmony - an NGO bringing healthcare to indigenous communities in Indonesia, Madagascar, and Brazil.

The Brazilian-born GP has built something that defies the usual Silicon Valley taxonomy. Not a traditional VC. Not a development finance institution. Something in between - and deliberately so.

"We take entrepreneurs who are great scientists or technologists and connect them with the industry leaders who can open the right doors for them."

- Enrico Carbone, General Partner, Reaction

That sentence does a lot of work. Reaction isn't positioning itself as a check-writer. It's positioning itself as a translator - between the world of science and the world of markets. Carbone's 22 years in capital markets gave him fluency on one side. His Stanford cohort, spread across 45 countries and multiple industries, gave him fluency on the other.

The portfolio reflects that logic. Zenysis handles data analytics for global health systems - the kind of company that needs both technical credibility and government relationships to scale. Mango Materials turns methane gas into biodegradable plastics - a climate play that requires industrial partnerships and regulatory navigation. JIFFY.ai brings automation intelligence to enterprises. Genetesis uses AI to detect heart disease and genetic conditions before they become crises.

None of these are pure consumer bets. All of them require exactly the kind of connector role Carbone describes.

Quick Facts

Born and raised in Sao Paulo, Brazil
Business degree from FGV EAESP (class of 1997)
Stanford Executive Program SEP '18
VP at Banco Santander, Miami (2001-2006)
Managing Director, BR Partners (2009-2018)
Co-founded Reaction with Dan Matthies in 2019
Named Stanford GSB Centennial Alumni Catalyst
Board member, Health in Harmony NGO
Invests $100K - $5M checks via IKJ Capital
Focus: North and South America cross-border growth

Career Arc

Twenty-Two Years, Then a Room at Stanford Changed Everything

The trajectory started in Sao Paulo. Carbone earned his business degree from FGV EAESP in 1997 - one of Brazil's most demanding business programs, the kind of institution that places graduates directly into international finance. From there it was a steady climb through global banking institutions: Santander in Miami through 2006, then Credit Suisse and Merrill Lynch, then a long stint at BR Partners running M&A, capital markets, and private equity restructuring.

By 2018 he was a Managing Director at Brazil's largest independent bank. The kind of job people don't leave. But Carbone enrolled in Stanford's Executive Program anyway - not as a pivot, but as a temperature check. He wanted to understand where the world was heading.

What he found was a cohort unlike anything his banking career had exposed him to. Entrepreneurs, scientists, technologists, executives from across the Americas, Europe, Asia, and Africa - all asking the same general question: how do we deploy capital more intelligently toward the world's actual problems?

The fund idea crystallized inside the classroom walls of room W250. Carbone and Dan Matthies didn't just ask classmates to become LPs. They asked them to become active participants - advisors, deal sourcers, door-openers. The W250 Venture Fund wasn't built from institutional capital. It was built from a community that already trusted each other.

That community structure became Reaction's structural advantage. With alumni in 45 countries across health, climate, enterprise, and government sectors, the network can do things a traditional VC firm cannot: validate deals in markets where no Sand Hill Road firm has relationships, open doors with ministries of health, connect a climate tech founder in California with a utilities executive in Brazil.

1997

Graduated from FGV EAESP - Sao Paulo's top-ranked business school

2001 - 2006

VP at Banco Santander SA in Miami - first international post

2006 - 2009

Investment banking roles at Credit Suisse and Merrill Lynch

2009 - 2018

Partner and Managing Director at BR Partners - M&A, capital markets, PE restructuring

2018

Stanford Executive Program (SEP '18) - the classroom where everything changed

2019

Co-founded Reaction with Dan Matthies; launched W250 Venture Fund; joined Health in Harmony board

2020 - present

Founding Managing Partner at Irukandji Capital (IKJ Capital) - Health Innovation Funds I and II

2022

Reaction launched Climate Innovations Fund as second fund vehicle

2024

Named Stanford GSB Centennial Alumni Catalyst for contributions to the alumni community

The Fund

Reaction: What Happens When a Classroom Becomes a Cap Table

Reaction operates two distinct fund vehicles. The W250 Venture Fund - named after the Stanford room where the idea was born - focuses on early-stage companies addressing global health and broad technology challenges. The Climate Innovations Fund, launched as the second vehicle, focuses specifically on scalable solutions to climate change: thermal energy storage, energy grid reliability, biodegradable materials, and climate resilience infrastructure.

The fund's structural bet is that impact and returns are not competing objectives. Carbone built Reaction's portfolio on companies with measurable outcomes - not just financial metrics but lives affected, emissions reduced, materials diverted from landfill. The "improve one billion lives" goal is not marketing copy. It's the performance benchmark the team uses internally to evaluate portfolio companies.

What makes the Reaction model unusual is the dual role of its LP community. When a portfolio company needs to enter a new market, Carbone can tap an LP who is an industry leader in that geography. When a founder needs validation of a technical hypothesis, there is likely an LP with domain expertise available. The 45-country footprint means Reaction's deals benefit from a form of distributed due diligence that no traditional fund structure could replicate.

Co-founder Dan Matthies handles complementary responsibilities, with both partners emphasizing accountability and decisive execution as core operating principles. It is a partnership built on the understanding that impact VC moves slowly when it shouldn't - and Reaction is trying to change that.

Fund Overview

Climate Tech

85%

Health Tech

80%

Deep Tech

70%

Enterprise AI

60%

Bio Materials

55%

* Illustrative portfolio sector weighting

Portfolio Spotlight

The Companies Carrying the Thesis Forward

🌿

Mango Materials

Climate Tech

Converts methane gas into biodegradable plastics using microorganisms - attacking the plastic waste crisis from an unexpected direction.

💓

Genetesis

Health AI

AI-powered technology for heart disease prediction and genetic condition detection - moving diagnosis from reactive to preventive.

📊

Zenysis

Global Health Data

Data analytics platform for global health systems, used by governments and NGOs to make better public health decisions at scale.

⚡

JIFFY.ai

Enterprise AI

Automation intelligence for enterprise workflows - raised a Series B with Reaction as a key backer.

🔬

Shift Bioscience

Longevity

Cellular reprogramming to reverse biological aging - one of the most ambitious bets in the IKJ Capital health portfolio.

🧠

Superpower

Health Tech

Consumer health technology platform in the IKJ Capital portfolio, focused on personal health optimization.

🩺

Eli Health

Health Innovation

Early-stage health technology company addressing chronic conditions - part of the IKJ Capital Health Innovation Fund.

🌍

Mevo

Healthcare Systems

Healthcare technology systems company where Carbone serves as board member through IKJ Capital's health fund.

Second Fund

IKJ Capital: The Parallel Bet on Human Longevity

Running two fund vehicles simultaneously is unusual. Most GPs pick a lane. Carbone chose not to - and the two funds illuminate different facets of the same underlying thesis: that the most transformative companies solve problems at the intersection of science, scale, and access.

Irukandji Capital (IKJ Capital) operates as a focused health technology vehicle, managing Health Innovation Funds I and II. The investment parameters are defined: checks from $100,000 to $5 million, with a sweet spot around $2.5 million. Stage focus is Seed and Series A. Geography spans North and South America, with Carbone's Brazilian roots giving IKJ particular credibility in Latin American health markets that most Bay Area health funds ignore.

The portfolio reveals a clear theory of change. Mental health, chronic conditions, and longevity extension are not three random bets - they are the three largest unmet needs in global healthcare, and each of them is experiencing simultaneous breakthroughs in AI, genomics, and digital health infrastructure. Shift Bioscience's cellular reprogramming work sits at the extreme end of that spectrum: the science of reversing biological aging, once considered fringe, is attracting serious capital and even more serious scrutiny.

Carbone's decision to back cellular reprogramming at the early stage - while also running a climate fund and sitting on an NGO board serving indigenous rainforest communities - describes a particular kind of investor: one for whom the size of the problem is an asset, not a liability.

The Irukandji jellyfish, for what it's worth, is the world's most venomous marine creature. Whether the fund name is a warning or a claim about potency is left to the reader.

$100K

Minimum check size. IKJ Capital enters early - before most institutional health funds are looking.

$5M

Maximum check size, with a $2.5M sweet spot at Seed and Series A stages.

3

Core focus areas: mental health innovation, chronic conditions, and longevity/healthspan extension.

Beyond the Portfolio

Health in Harmony: Where the Philosophy Gets Personal

Board membership at an NGO rarely signals anything important about an investor. Most such roles are perfunctory. Carbone's position at Health in Harmony - which he joined in 2019, the same year he co-founded Reaction - operates differently.

Health in Harmony works from a counterintuitive premise: the best way to protect rainforests is to provide high-quality healthcare to the communities that live near them. When people have access to affordable healthcare, they don't need to log the forest to pay for medical expenses. The organization operates in Indonesia, Madagascar, and Brazil - three of the world's most biodiverse ecosystems and three of the most at-risk.

Carbone is Brazilian. He grew up with the Amazon as a backdrop - political, ecological, economic. His board membership at Health in Harmony is not a charitable gesture. It is a continuation of the same logic that runs through every investment he makes: that systems-level thinking, applied to the right interventions, can generate outcomes that purely financial or purely altruistic approaches cannot.

The framework maps cleanly. At Reaction, they find scientists and connect them with industry leaders who open doors. At IKJ, they fund the science of keeping humans alive longer and in better health. At Health in Harmony, the intervention is healthcare provision that generates biodiversity preservation as a byproduct. Three different vehicles. One operating theory.

Operating Across Three Vehicles

Reaction Global

W250 Venture Fund + Climate Innovations Fund. Seed to Series B. 45-country LP network.

IKJ Capital

Health Innovation Funds I & II. $100K-$5M checks. Mental health, chronic conditions, longevity.

Health in Harmony

NGO Board Member since 2019. Healthcare for indigenous communities in Indonesia, Madagascar, and Brazil.

Education & Recognition

The Classroom That Became a Career

Carbone's formal education spans two continents and three decades. His undergraduate training at FGV EAESP in Sao Paulo - among Brazil's most rigorous business programs - gave him the foundation for a career in international capital markets. The training was technical, the culture demanding, and the alumni network deeply embedded in Brazilian finance and industry.

Twenty-one years later, Stanford's Executive Program gave him something different: not technique, but perspective. The SEP '18 cohort was international, multi-sector, and - crucially - at a career stage where most participants were asking strategic rather than tactical questions. It was the right room at the right time.

The Stanford GSB's decision to name him a Centennial Alumni Catalyst - a recognition given to alumni whose contributions to the community are considered exemplary - reflects something Carbone's colleagues have noted repeatedly: he treats the network as a shared asset, not a personal resource. He helps classmates navigate early-stage VC investments. He speaks at GSB events. He has built Reaction in a way that keeps the original community central rather than peripheral.

That disposition - treating a network as something to steward rather than extract from - may be the most important thing Stanford gave him.

Education

Stanford Executive Program

SEP '18 · Stanford Graduate School of Business

Where the Reaction thesis was born. Alumni Catalyst recognition for contributions to the GSB community.

FGV EAESP

Business Administration · Class of 1997 · Sao Paulo, Brazil

Brazil's top-ranked business school. Foundation for a 22-year career in global investment banking.

The Useful Details

Things Worth Knowing

The W250 Venture Fund was named after the Stanford classroom where Carbone and co-founder Dan Matthies first conceived the idea. The room number is literally in the fund name.

Mango Materials - one of Reaction's portfolio companies - makes biodegradable plastics out of methane gas using microorganisms. It is one of the stranger climate solutions in any VC portfolio.

Carbone grew up in Sao Paulo, did a stint at Santander in Miami, and eventually landed in Palo Alto. Each move roughly doubled the scope of what he was working on.

Reaction's 150+ LP community spans 45 countries. For context, most small-to-mid VC funds have LPs in perhaps 3-5 countries. The geographic distribution is structural, not cosmetic.

Health in Harmony operates on the principle that providing healthcare to rainforest communities reduces illegal logging - because families don't have to sell timber to pay for medical emergencies. The intervention is healthcare. The outcome includes biodiversity preservation.

IKJ Capital's Shift Bioscience is developing cellular reprogramming technology - essentially trying to reverse biological aging at the cellular level. It is one of the most frontier bets in Carbone's dual-fund portfolio.

Share This Profile